Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan

Stopped early

Conditions studied: Mucositis, Multiple Myeloma and Plasma Cell Neoplasm

In brief

RATIONALE: Studying blood or mouthwash samples in the laboratory from patients receiving melphalan for cancer may help doctors learn more about changes that occur in DNA, identify biomarkers related to cancer, and help predict how patients will respond to treatment. PURPOSE: This clinical trial is studying common genetic mutations related to mucositis in patients with multiple myeloma receiving high-dose melphalan.

Key facts

Study ID

NCT00602147

Run by

Vanderbilt-Ingram Cancer Center

People needed

95

Starts

2007-07-01

Expected to finish

2010-04-01

Last updated by the study team

2013-03-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Vanderbilt-Ingram Cancer Center at Franklin — Nashville, Tennessee, United States
• Veterans Affairs Medical Center - Nashville — Nashville, Tennessee, United States
• Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.